Fortitude Family Office, LLC Kymera Therapeutics, Inc. Transaction History
Fortitude Family Office, LLC
- $305 Billion
- Q2 2025
A detailed history of Fortitude Family Office, LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Fortitude Family Office, LLC holds 18 shares of KYMR stock, worth $834. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18Holding current value
$834% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding KYMR
# of Institutions
180Shares Held
67.4MCall Options Held
223KPut Options Held
241K-
Price T Rowe Associates Inc Baltimore, MD6.7MShares$311 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.46MShares$299 Million2.86% of portfolio
-
Wellington Management Group LLP Boston, MA6MShares$278 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$278 Million1.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.23MShares$242 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.54B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...